相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges
Sofia Parrasia et al.
MOLECULAR PHARMACEUTICS (2022)
Sunflower Trypsin Inhibitor-1 (SFTI-1): Sowing Seeds in the Fields of Chemistry and Biology
Simon J. de Veer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment
Guihong Liu et al.
CELL PROLIFERATION (2021)
Trends in peptide drug discovery
Markus Muttenthaler et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Peptide and protein engineering by modification of backbone and sidechain functional groups
Shadi Kordbacheh et al.
POLYMER INTERNATIONAL (2021)
Recent advances in proteolytic stability for peptide, protein, and antibody drug discovery
Xianyin Lai et al.
EXPERT OPINION ON DRUG DISCOVERY (2021)
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
Zongru Jiang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Optimizing the anti-tumor efficacy of protein-drug conjugates by engineering the molecular size and half-life
Fabian Brandl et al.
JOURNAL OF CONTROLLED RELEASE (2020)
The anti-cancer properties of heparin and its derivatives: a review and prospect
Sai-Nan Ma et al.
CELL ADHESION & MIGRATION (2020)
Targeting VEGF-neuropilin interactions: a Promising antitumor strategy
Kewen Peng et al.
DRUG DISCOVERY TODAY (2019)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Natural Cyclic Peptides as an Attractive Modality for Therapeutics: A Mini Review
Muna Ali Abdalla et al.
MOLECULES (2018)
A peptide derived from apoptin inhibits glioma growth
Liqiu Zhang et al.
ONCOTARGET (2017)
Cyclic peptide therapeutics: past, present and future
Alessandro Zorzi et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2017)
TNNI1, TNNI2 and TNNI3: Evolution, regulation, and protein structure-function relationships
Juan-Juan Sheng et al.
GENE (2016)
Enhancing the circulating half-life and the antitumor effects of a tumor-selective cytotoxic peptide by exploiting endogenous serum albumin as a drug carrier
Tao Su et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Mechanisms and regulation of endothelial VEGF receptor signalling
Michael Simons et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Troponin-I enhances and is required for oncogenic overgrowth
Sergio Casas-Tinto et al.
ONCOTARGET (2016)
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
William R. Strohl
BIODRUGS (2015)
Peptide therapeutics: current status and future directions
Keld Fosgerau et al.
DRUG DISCOVERY TODAY (2015)
Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity
Madelane Teran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Amino-acid mutations to extend the biological half-life of a therapeutically valuable mutant of human butyrylcholinesterase
Lei Fang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models
Youzhi Xu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
Virginia Hernandez-Gea et al.
GASTROENTEROLOGY (2013)
High-level expression, purification, and characterization of Staphylococcus aureus dihydroorotase (PyrC) as a cleavable His-SUMO fusion
Lena Truong et al.
PROTEIN EXPRESSION AND PURIFICATION (2013)
The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
A. Amini et al.
CURRENT CANCER DRUG TARGETS (2012)
Biological Synthesis of Circular Polypeptides
Teshome L. Aboye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A polypeptide from shark troponin I can inhibit angiogenesis and tumor growth
Qiuling Xie et al.
MOLECULAR BIOLOGY REPORTS (2012)
Biological Activities of Natural and Engineered Cyclotides, a Novel Molecular Scaffold for Peptide-Based Therapeutics
Angie E. Garcia et al.
Current Molecular Pharmacology (2012)
Biosynthesis and Antimicrobial Evaluation of Backbone-Cyclized α-Defensins
Angie E. Garcia et al.
BIOCHEMISTRY (2011)
An overview of once-weekly glucagon-like peptide-1 receptor agonists-available efficacy and safety data and perspectives for the future
S. Madsbad et al.
DIABETES OBESITY & METABOLISM (2011)
Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607
Meltem Ocak et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
Carlos Mas-Moruno et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Cyclotides, A Promising Molecular Scaffold for Peptide-Based Therapeutics
Krishnappa Jagadish et al.
BIOPOLYMERS (2010)
Development of Potent Glucagon-like Peptide-1 Agonists with High Enzyme Stability via Introduction of Multiple Lactam Bridges
Eunice N. Murage et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Antimicrobial peptides The ancient arm of the human immune system
Jochen Wiesner et al.
VIRULENCE (2010)
A Straight Path to Circular Proteins
John M. Antos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
Andrew X. Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Oral delivery of peptide drugs - Barriers and developments
JH Hamman et al.
BIODRUGS (2005)
SUMO fusion technology for difficult-to-express proteins
TR Butt et al.
PROTEIN EXPRESSION AND PURIFICATION (2005)
Activity of hydrolytic enzymes in tumour cells is a determinant for anti-tumour efficacy of the melphalan containing prodrug J1
J Gullbo et al.
JOURNAL OF DRUG TARGETING (2003)
Troponin I binds polycystin-L and inhibits its calcium-induced channel activation
Q Li et al.
BIOCHEMISTRY (2003)
Quick measurement of protein sulfhydryls with Ellman's reagent and with 4,4'-dithiodipyridine
CK Riener et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2002)
Clinical pharmacokinetics of depot leuprorelin
P Periti et al.
CLINICAL PHARMACOKINETICS (2002)
Novel peptide conjugates for tumor-specific chemotherapy
M Langer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
分享论文
